Study objectives: To examine predictors of sleep-disordered breathing in patients with cystic fibrosis (CF) and moderate-to-severe lung disease using a comprehensive evaluation of both sleep and daytime function. Design: Cross-sectional analysis of sleep studies, lung function, respiratory muscle strength, and evening and morning arterial blood gas measurements in patients with stable CF. A questionnaire addressing sleep quality was administered. Forward stepwise regression analysis was used to identify the parameters that best predict sleep-related desaturation, hypercapnia, and respiratory disturbance. Key words: cystic fibrosis; hypoxemia; sleep-disordered breathing Abbreviations: ABG ϭ arterial blood gas; BMI ϭ body mass index; CF ϭ cystic fibrosis; EMG ϭ electromyogram; Kco ϭ carbon monoxide transferred per liter of lung volume; NREM ϭ non-rapid eye movement; Pemax ϭ expiratory muscle pressure at total lung capacity; Pimax ϭ inspiratory muscle pressure at residual volume; PSQI ϭ Pittsburgh sleep quality index; RDI ϭ respiratory disturbance index; REM ϭ rapid eye movement; RV ϭ residual volume; Spo 2 ϭ oxyhemoglobin saturation; Spo 2 min⅐av ϭ minimum average oxyhemoglobin saturation; Tcco 2 ϭ transcutaneous carbon dioxide; TLC ϭ total lung capacity; TST ϭ total sleep time S leep hypoxemia was first described in patients with cystic fibrosis (CF) Ͼ 20 years ago. Muller and colleagues 1 and Tepper and colleagues 2 showed that the desaturation occurred predominantly in rapid eye movement (REM) sleep and that hypoventilation was a contributing factor. Hypoxia is thought to be the main etiologic factor in the development of cor pulmonale in patients with CF. 3 Right ventricular hypertrophy is due to chronic pulmonary hypertension resulting primarily from hypoxic pulmonary vasoconstriction. Pulmonary artery systolic pressure has been shown 4 to correlate highly with awake, sleep, and postexercise oxyhemoglobin saturation (Spo 2 ) by pulse oximetry; moreover, a higher mortality is seen in patients with pulmonary hypertension. Therefore, it is important to reliably predict sleep-related hypoxia, as this could influence the timing of the initiation of treatment aimed at preventing sleep-related desaturation and reducing or minimizing the load on the cardiovascular system.
S
leep hypoxemia was first described in patients with cystic fibrosis (CF) Ͼ 20 years ago. Muller and colleagues 1 and Tepper and colleagues 2 showed that the desaturation occurred predominantly in rapid eye movement (REM) sleep and that hypoventilation was a contributing factor. Hypoxia is thought to be the main etiologic factor in the development of cor pulmonale in patients with CF. 3 Right ventricular hypertrophy is due to chronic pulmonary hypertension resulting primarily from hypoxic pulmonary vasoconstriction. Pulmonary artery systolic pressure has been shown 4 to correlate highly with awake, sleep, and postexercise oxyhemoglobin saturation (Spo 2 ) by pulse oximetry; moreover, a higher mortality is seen in patients with pulmonary hypertension. Therefore, it is important to reliably predict sleep-related hypoxia, as this could influence the timing of the initiation of treatment aimed at preventing sleep-related desaturation and reducing or minimizing the load on the cardiovascular system. Awake resting Spo 2 Ͻ 94% and an FEV 1 Ͻ 65% predicted have been suggested 5, 6 as the variables with the most significant correlation with sleeprelated desaturation in patients with CF. There is limited information on the predictive value of daytime Paco 2 in sleep-disordered breathing, and no studies have assessed predictors of sleep-related changes in carbon dioxide levels or indexes of nocturnal respiratory disturbance in patients with CF. The aim of this study was to compare sleep variables of oxygenation, changes in carbon dioxide, and respiratory disturbance to daytime measurements of lung function, respiratory muscle strength, arterial blood gas (ABG) measurements, and subjective sleep quality in patients with CF. Furthermore, we aimed to examine for the ability of daytime variables to have significant predictive value for sleep-disordered breathing.
Materials and Methods
We studied adult patients with CF with moderate-to-severe lung disease while in a stable clinical condition, which was defined according to the criteria of Fuchs et al. 7 Patients were invited to participate in the study if their FEV 1 was Ͻ 65% predicted and/or their awake resting Spo 2 was Ͻ 94%. Diagnostic sleep studies were performed with the patients going to bed at a time of their preference, usually between 10 pm and 11 pm, and they were awakened at 6 am.
This study was conducted at Royal Prince Alfred Hospital in Sydney, Australia, and approved by the ethics committee of our institution (protocol No. X97-0204). Written, informed consent was obtained from all patients.
Anthropometric and Lung Function Measurements
Anthropometric and lung function data were obtained on the day of the diagnostic sleep study. Measurements of spirometry were performed using a mass flow sensor (Sensormedics Vmax 20; Sensormedics Corporation; Yorba Linda, CA), which was calibrated before each study and compared with normal predicted values of Quanjer et al. 8 Lung volumes were determined by body plethysmography (Gould 2800; Gould Electronics; Dayton, OH). Results were compared with normal predicted values of Goldman and Becklake. 9 Inspiratory muscle pressure at residual volume (Pimax) and expiratory muscle pressure at total lung capacity (Pemax) were recorded using a hand-held pressure gauge, and the results were compared with normal predicted values of Wilson et al. 10 A gas chromatograph (1085 D Series PF/Dx; Medical Graphics Corporation; St. Paul, MN) was used to measure carbon monoxide transferred per liter of lung volume (Kco). The normal predicted value for Kco was 6.9 mL CO/mm Hg/min (standard temperature and pressure, dry), a value based on mean laboratory values for normal nonsmoking healthy adults obtained in our laboratory.
ABG Tensions
Initial awake ABG tensions were obtained with the patient seated and breathing room air, usually in the late afternoon prior to the sleep study. Morning ABG measurements were taken immediately on awakening, so that any delay from sleep to wakefulness was minimized.
Sleep Study Recordings
During polysomnography, continuous recordings were made on a computerized system (Sleepwatch; Compumedics; Melbourne, Australia). Sleep stage was determined from two channels of EEG (C3/A2, O2/A1), two channels of electro-oculogram (right outer canthus/A1, left outer canthus/A2), and from the submental electromyogram (EMG). Respiratory variables were monitored using abdominal and thoracic impedance bands for chest wall movement and diaphragm EMG electrodes to reflect respiratory effort. Nasal airflow was measured using nasal prongs attached to a flow sensor (AutoSet; ResMed; Sydney, Australia). Spo 2 was measured with a finger probe (model 3700e; Ohmeda; Boulder, CO). The resting awake value of Spo 2 was noted, and Spo 2 recording continued overnight. Transcutaneous carbon dioxide (Tcco 2 ) was also measured continuously overnight (TCM3; Radiometer; Copenhagen, Denmark). Tcco 2 and Spo 2 were recorded simultaneously on both the Sleepwatch system as well as a personal computer.
Sleep stages were scored in 30-s epochs according to the standard criteria of Rechtschaffen and Kales. 11 An EEG arousal was defined as an abrupt increase in EEG frequency for Ն 3 s that in REM sleep was accompanied by an increase in submental EMG amplitude. Sleep efficiency was defined as the total sleep time (TST) as a percentage of the time available for sleep. Apnea was defined as cessation of airflow for Ն 10 s, or a cessation of airflow for Ͻ 10 s with an oxygen desaturation of Ն 3% or an arousal. Hypopnea was defined as a reduction in amplitude of airflow, or thoracoabdominal wall movement of Ͼ 50% for Ն 10 s, or a reduction in airflow or thoracoabdominal wall movement of Ͼ 50% for Ͻ 10 s if it was accompanied by an oxygen desaturation of Ն 3% or an arousal. The number of apneas and hypopneas per hour of non-rapid eye movement (NREM), REM, and TST were calculated and reported as the respiratory disturbance index (RDI).
The absolute minimum sleep Spo 2 was documented for the entire night but also for REM and NREM sleep. The percentage of TST, REM, and NREM sleep time with Spo 2 Յ 90% was calculated. The minimum average Spo 2 (Spo 2 min⅐av) was calculated as the mean of the minimum value for Spo 2 in each 30-s epoch of sleep. Spo 2 min⅐av was calculated for TST, NREM sleep time, and REM sleep time.
Respiratory events leading to desaturation and increases in carbon dioxide occur predominantly in REM sleep in the CF population. These changes in carbon dioxide can be represented by the change in Tcco 2 from NREM to REM sleep, or the maximum Tcco 2 measured during the night compared with a baseline Tcco 2 reading. The change in Tcco 2 from NREM to REM sleep in our study was calculated for each REM period. Due to the drift often seen in the Tcco 2 trace, a line of best fit was drawn between four points on the Tcco 2 trace: one at the start and end of each REM period, taking into account the approximately 3-min time delay for the device, and a point 5 min prior to and following each REM period as long as the Tcco 2 reading was stable. A perpendicular line was then drawn to the peak Tcco 2 reading for that REM period being measured (Fig 1) . A weighted average was then obtained for the ⌬Tcco 2 for each subject. Tcco 2 awake was the baseline value recorded at least 7 min after probe placement while the patient was breathing spontaneously.
Questionnaire Data
The Pittsburgh sleep quality index (PSQI) was completed on the day of the diagnostic sleep study. Administration of the questionnaire occurred during face-to-face interviews, with nondirectional guidance. The PSQI is a self-rated questionnaire that assesses sleep quality and disturbances over a 1-month time interval and has been validated for clinical populations. 12 
Data Analysis and Statistics
Linear correlation analyses were performed between awake and sleep measurements, but due to the large number of correlations being performed, we chose to analyze data by fitting the variables into a forward stepwise regression model to determine the most important predictor variables. Daytime variables used as potential predictor variables included lung function variables (FEV 1 percent predicted, FVC percent predicted, total lung capacity [TLC] percent predicted, residual volume [RV] percent predicted, RV/TLC percent predicted, functional residual capacity percent predicted, Kco percent predicted); respiratory muscle strength measurements (Pimax percent predicted and Pemax percent predicted); anthropometric values (age, sex, and body mass index [BMI]); evening and morning ABG measurements (pH, Pao 2 , Paco 2 ); and the PSQI score. In order to reduce the possibility of a type-1 error, only three sleep variables were chosen as outcome variables: Spo 2 min ⅐ av, ⌬Tcco 2 from NREM to REM sleep, and REM RDI.
As awake resting Spo 2 and evening Pao 2 are both measurements of the level of arterial blood oxygenation, it is logical that they are correlated highly with one another. Therefore, when fitting them into a model of forward stepwise regression, once one is selected the other does not provide any additional information. Hence, in our forward stepwise regression calculations, evening Pao 2 was included as a potential predictor variable and awake resting Spo 2 was not. Data are reported as mean Ϯ 1 SD. Results were considered statistically significant at the p Ͻ 0.05 level.
Results

Anthropometric and Lung Function Data
The mean age of the 32 subjects (17 male and 15 female) was 27 Ϯ 8 years. Anthropometric and daytime lung function are presented in Table 1 . All subjects had moderate-to-severe lung disease with FEV 1 ranging from 18 to 59% of predicted values. Subjects had evening Pao 2 values ranging between 42 mm Hg and 84 mm Hg, and nine subjects were hypercapnic during wakefulness (Paco 2 Ͼ 45 mm Hg). Mean respiratory muscle strength was in the normal range. Subjects were hyperinflated with an RV/TLC of 223 Ϯ 34% of predicted.
Three of 16 subjects with an awake resting Spo 2 Ն 94% had an Spo 2 min⅐av Ͻ 90%, while 12 of 16 subjects with a resting Spo 2 Ͻ 94% had an Spo 2 min⅐av Յ 90%. Thirty of 32 patients had an absolute minimum sleep Spo 2 of Յ 90% (Table 2) . Subjects had a mean awake Tcco 2 of 47 Ϯ 7 mm Hg, ranging from 37 to 70 mm Hg. The maximum sleep Tcco 2 was 55 Ϯ 10 mm Hg, ranging from 41 to 82 mm Hg. The rise in Tcco 2 from NREM to REM sleep was 2.1 Ϯ 1.6 mm Hg, ranging from an increase of zero to 5.6 mm Hg ( Table 2 ). The mean values for REM, NREM, and TST RDI are shown in Table 3 . Subjects had a mean NREM RDI of 0.7 Ϯ 1.3 events per hour, REM RDI of 12.2 Ϯ 11.4 events per hour, and TST RDI of 3.2 Ϯ 3.4 events per hour.
Relationship Between Baseline Data and Oxygenation During Sleep
The minimum sleep Spo 2 and the Spo 2 min ⅐ av correlated highly with one another (r ϭ 0.93; p Ͻ 0.0001). The same was true for the Spo 2 min ⅐ av and the percentage of sleep time with Spo 2 Յ 90% (r ϭ 0.79; p Ͻ 0.0001). Therefore, Spo 2 min ⅐ av was 
Relationship Between Baseline Data and Carbon Dioxide Levels During Sleep
The maximum Tcco 2 measured and the mean change in Tcco 2 from NREM to REM (⌬Tcco 2 ) sleep are correlated with one another (r ϭ 0.51; p Ͻ 0.01), and since the size of the ⌬Tcco 2 reflects Evening Pao 2 (p Ͻ 0.001) was the only variable identified in a forward stepwise regression model as being predictive of the change in carbon dioxide from NREM to REM sleep as represented by ⌬Tcco 2 (r 2 ϭ 0.37; p Ͻ 0.001; Fig 3) . Other measured variables did not add significantly to the ability of evening Pao 2 to account for the variability seen in ⌬Tcco 2 . The equation to calculate the predicted change in Tcco 2 from NREM to REM sleep is as follows:
Relationship Between Patient Characteristics and RDIs During Sleep
The RDI was significantly greater during REM sleep than during NREM sleep (p Ͻ 0.0001), with a mean NREM RDI of 0.7 Ϯ 1.3 events per hour and a REM RDI of 12.2 Ϯ 11.4 events per hour ( Table  3) . As this patient group shows their greatest respiratory disturbance during REM sleep, the REM RDI was chosen as the variable for the calculations of the relationship with lung function parameters, respiratory muscle strength, awake resting Spo 2 , evening and morning ABG measurements, and the PSQI.
Pemax percent predicted was the only variable to show any correlation with REM RDI (r ϭ Ϫ 0.47; p Ͻ 0.01). Similarly, in a forward stepwise regression, Pemax percent predicted was found to be the only variable with predictive power for REM RDI (r 2 ϭ 0.22; p Ͻ 0.01). The equation to calculate the predicted REM RDI is as follows:
REM RDI ϭ 26.919 Ϫ (0.154 ϫ Pemax%predicted)
Discussion
Using rigorous statistical analysis of a type that has not usually been employed in many previous studies 6, 13, 14 of sleep-disordered breathing in patients with CF, we found that evening Pao 2 and morning Paco 2 were the variables that were the most predictive of sleep-related oxygenation in patients with moderate-to-severe lung disease. These variables accounted for 74% of the variability seen in the Spo 2 av percentage. Assessment of individual correlations between the awake and asleep measurements made in this study showed that other variables of lung function and gas exchange were significantly correlated with measures of sleep-related oxygenation, although they did not add significantly to the predictive ability of the evening Pao 2 and morning Paco 2 in the forward stepwise regression model. Previously, Versteegh and colleagues 5 showed that an awake resting Spo 2 of 93.8% was the most discriminatory for predicting sleep-related Spo 2 , defined as one hourly mean Spo 2 of Յ 90%, with a positive predictive value of 50%, and that the addition of other variables, including exercise parameters and lung function, did not add significantly to the discriminatory power. 5 ABG tensions, measures of carbon dioxide levels during sleep, or polysomnography allowing for sleep staging and respiratory event scoring were not measured in that study. Our data have demonstrated the additional value of measuring morning Paco 2 along with evening Pao 2 for predicting sleep-related Spo 2 , and provides the clinician with a predictive equation that describes a continuum rather than a probability (50%) at a single point (93.8%). In addition, the current study is to our knowledge the first to examine the ability to predict changes in carbon dioxide and indexes of respiratory disturbance during sleep in this patient group.
An interesting observation from our work was that 3 of 16 patients, despite an awake resting Spo 2 of Ն 94%, had an Spo 2 av of Ͻ 90%. Sleep-related hypoxemia would have been missed if sleep studies were not performed in these patients. Frangolias and colleagues 15 recently reported sleep studies in a group of patients with CF, with a wide spectrum of lung disease. This study was designed to assess for the ability to predict nocturnal Spo 2 using daytime pulse oximetry, exercise testing, and spirometry. There was no assessment of respiratory disturbance, sleep-related carbon dioxide changes, measurements of ABG tensions, nor full polysomnography. All patients with an awake resting Spo 2 of Ͻ 93% desaturated nocturnally, but there was a heterogenous response with regard to nocturnal desaturation with values of awake resting Spo 2 of Ͼ 93%. 15 Nocturnal desaturation was found to be uncommon in patients with milder lung disease (FEV 1 Ͼ 65% predicted); however, when using FEV 1 and awake resting Spo 2 alone, they were only able to correctly predict 26% of all patients with clinically significant nocturnal desaturation, which they defined as Spo 2 Ͻ 90% for Ͼ 5% of the night. 15 Further studies in patients with CF and mild lung disease, using full polysomnography and a comprehensive battery of tests including complete pulmonary function testing and ABG tension measurements, may allow us to better determine if nonsleep study measurements can predict when patients with CF first present with sleep-disordered breathing.
Previous studies have used various methods of describing desaturation during sleep. However, a definitive measure of sleep Spo 2 has yet to be determined. Variables described have included the greatest percentage fall in Spo 2 , 3,16 the percentage of time spent with Spo 2 Ͼ 90% and Ͻ 90%, 6 minimum sleep Spo 2 , 1-3 mean sleep Spo 2 , 14 lowest hourly mean, 5 and mean minimum Spo 2 . 17 In this study, we reported the relationship between the minimum sleep Spo 2 , Spo 2 av, and percentages of time with Spo 2 Յ 90%. In order to reduce the possibility of type-1 error, only one measure of oxygenation during sleep could be chosen as an outcome variable in this study. As the absolute minimum sleep Spo 2 may not appropriately reflect the subject's oxygenation for the entire night, we reasoned that the Spo 2 av more accurately quantifies sleep oxygenation due to the high sampling rate, and it was therefore chosen as the variable to reflect oxygenation during sleep in this study.
Although Versteegh and colleagues 5 found that sleep-related desaturation occurred only in subjects with an FEV 1 Ͻ 65% predicted in their study, spirometry did not add significantly to the discriminatory power of resting Spo 2 to predict sleep-related desaturation. Our study did not include subjects with an FEV 1 Ͼ 65% of predicted, and thus the range in spirometry was limited. Our results in patients with moderate and severe lung disease showed no additional predictive information to be gained by lung function parameters when performed in conjunction with ABG tension measurement. Similarly, in a study of overnight pulse oximetry in patients with CF, FEV 1 was shown to be poorly correlated with Spo 2 during sleep, defined as percentage of TST with Spo 2 Ͻ 90%. 6 Other studies that have examined for relationships between lung function and overnight oximetry have reported significant correlations with measures of severity of lung disease, including measures of lung hyperinflation 3, 13 and airflow obstruction. 3, 6, 14 No significant correlations were shown between respiratory muscle strength or nutritional status in a previous study 13 of sleep-related desaturation in patients with CF. Despite the individual correlations seen between measurements of lung function and sleep-related desaturation in the abovementioned studies as well as this present study, we conclude that for patients with moderate-to-severe lung disease, lung function measurements when performed in conjunction with ABG measurements do not add to our ability to predict desaturation during sleep.
A novel feature of this study was the assessment of the ability to predict changes in carbon dioxide levels during sleep and indexes of nocturnal respiratory disturbance. In the forward stepwise regression model, the evening Pao 2 was predictive of the Tcco 2 from NREM to REM sleep, but it accounted for a lesser degree of the variability than the variables that were found to be predictive of Spo 2 av.
Pemax percent predicted was found to correlate significantly with and be predictive of REM RDI, although it accounted for only 22% of the variability in the REM RDI. Pemax may reflect the strength of cough. Cough has been described as contributing significantly to sleep disruption in patients with CF, 16 although the contribution of cough to sleep disruption in this study was not quantified.
In this study, we have shown that evening Pao 2 and morning Paco 2 , rather than measurements of lung function, were predictive of nocturnal oxygenation as represented by TST Spo 2 av in patients with CF and moderate-to-severe lung disease. Evening Pao 2 was found to contribute significantly to the ability to predict both nocturnal desaturation and the rise in Tcco 2 from NREM to REM sleep.
